Global Stock News

Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains

Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.

  • If you are wondering whether Amgen’s current share price reflects its true worth, starting with a clear look at what the market is paying for its fundamentals can help ground your view.

  • The stock last closed at US$336.23, with returns of 2.2% over the past week, a decline of 4.2% over the past month, a 2.6% gain year to date and a 28.6% gain over the past year. The 3 year and 5 year returns sit at 64.4% and 56.2% respectively.

  • Recent price moves sit against a backdrop of ongoing product developments, regulatory milestones and industry news that continue to influence how investors think about large biotech valuations….

Source link

Share this article

Scroll to Top